Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition
This article was originally published in The Rose Sheet
Executive Summary
Prolacta Bioscience developed human milk-based formula fortifier for full-term infants born with conditions that make them vulnerable to nutrition deficiencies. Pending results from research at 12 US hospitals, the product would roll out commercially in 2018.